HPV vaccines gain traction in India, though cost keeps reach limited

📅 Published: February 10, 2026 | 📂 Category: Uncategorized

HPV, or human papillomavirus, is linked to several types of cancer, including cervical, anal, and throat cancers. India’s HPV vaccine market was worth ₹91 crore as of January 2026, on a moving annual total basis, according to pharma intelligence platform Pharmarack.

Read more


📱 Share on WhatsApp 🌐 View Original Article

Leave a Reply

Your email address will not be published. Required fields are marked *